Gujarat Inject fills top post after chairman's death, but new MD is from plastics
The board appoints Murli Nair as MD for a three-year term effective July 6, replacing Deepak Bachwani who died June 23. Nair's background is in plastics, not solar, a potential friction point given the company's pivot.
— 5 earlier stories on Gujarat Inject (Kerala) Ltd. →What's new
- Board appoints Murli Shivshankaran Nair as MD for three years, effective 6 July 2026.
- Nair fills the leadership vacuum left by the sudden death of chairman/CFO Deepak Bachwani on 23 June.
- His expertise is in plastics, while the company is trying to pivot to solar renewable energy.
Why this matters
For a nano-cap with a ₹180 cr market cap and just 1% ROE, the swift appointment stabilises operations after a traumatic loss. But Nair's background in plastics (a sector the company is exiting) raises doubts about whether the solar pivot has full management backing.
What we're watching
- Nair's first public statements on strategy, especially the solar transition.
- Whether the company can sustain the recent solar order momentum (₹14.49 cr and ₹1.07 cr orders).
- Any further board changes or a new CFO appointment to fill the remaining gap.
The full read
Gujarat Inject (Kerala) acted quickly to replace its chairman and whole-time director who died on 23 June. The board has appointed Murli Shivshankaran Nair as Managing Director for a three-year term starting 6 July. For a nano-cap with a ₹180 cr market cap and 1% ROE, that speed is reassuring. But Nair comes from the plastics industry, exactly the sector the company is trying to exit as it pivots to solar energy. The contrast is sharp. Gujarat Inject has won two solar orders this month, worth ₹14.49 cr and ₹1.07 cr (nearly half of ₹31 cr quarterly sales), which suggests the pivot has real traction. Now the new MD must convince investors he is behind it. The leadership vacuum is filled; the strategic question is not.
Questions answered
- Who is Murli Shivshankaran Nair?
- He has deep experience in the plastic industry, which Gujarat Inject is trying to pivot away from. He is not related to any existing directors.
- Why was the MD position vacant?
- The previous whole-time director, CFO, and chairman Deepak Diwan Bachwani died on 23 June, leaving a leadership vacuum.
- When does Nair's term start?
- His appointment as Managing Director is effective 6 July 2026, for a three-year term.
- How does this affect the company's solar pivot?
- Nair's plastics background contrasts with the company's stated move into solar energy. Investors will watch for clarity on strategy, especially after two recent solar orders worth ₹14.49 cr and ₹1.07 cr.
- What are Gujarat Inject's recent financials?
- In the March 2026 quarter, it reported sales of ₹31 cr and net profit of ₹2 cr. Trailing revenue growth is 624.5% but ROE is just 1.0%.
- Is this appointment a positive signal?
- Filling the top role within days of the death is stabilising. However, the expertise mismatch with the solar pivot keeps the outlook strained.
Gujarat Inject (Kerala) Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on GUJINJEC →- 6 Jul 2026 · 5:46 PM IST Gujarat Inject fills top post after chairman's death, but new MD is from plastics
- 16d ago Gujarat Inject loses Chairman, CFO & Whole-Time Director in single death
- 29d ago Gujarat Inject lands ₹14.49 cr solar order, nearly 40% of annual revenue
- 32d ago Gujarat Inject wins ₹1.07 cr solar module order from Ottire Lifestyle
- 51d ago Gujarat Inject (Kerala) posts 7x revenue jump in Q4, flips to profit